http://www.fda.gov/medical-devices/medical-device-recalls/abbott-medical-recalls-dragonfly-opstar-imaging-catheter-potential-loose-catheter-marker-band-may

http://www.fda.gov/vaccines-blood-biologics/recalls-biologics/urgent-voluntary-recall-corneagen-cornea-cornea-patch-grafts-corneagen-voluntarily-recalling-corneal

http://www.fda.gov/vaccines-blood-biologics/recalls-biologics/2022-biologics-recalls

FDA Flexibilities to Yield Millions of Cans of Additional Infant Formula in Coming Months to Increase Supply Available to U.S. Consumers
http://www.fda.gov/news-events/press-announcements/fda-flexibilities-yield-millions-cans-additional-infant-formula-coming-months-increase-supply

FDA Roundup: May 24, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-24-2022

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-issues-voluntary-nationwide-recall-one-lot-anagrelide-capsules-usp-05-mg-due-dissolution-test

FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder
http://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-eosinophilic-esophagitis-chronic-immune-disorder

FDA Roundup: May 20, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-20-2022

FDA Urges Drug Manufacturers to Develop Risk Management Plans to Promote a Stronger, Resilient Drug Supply Chain
http://www.fda.gov/news-events/press-announcements/fda-urges-drug-manufacturers-develop-risk-management-plans-promote-stronger-resilient-drug-supply

New FDA Draft Guidance Aims to Increase Safety Information About Dietary Supplement Marketplace
http://www.fda.gov/news-events/press-announcements/new-fda-draft-guidance-aims-increase-safety-information-about-dietary-supplement-marketplace